Showing results (21-30 of 237) with videos related to
Sort By:
Pageof 24
Metabolic Syndrome and Related Disorders|November 23, 2012
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucoseMatilda Florentin, Evangelos N Liberopoulos, Christos V Rizos, et al.Clinical Therapeutics|April 20, 2010
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective studyChristos V Rizos, Haralampos J Milionis, Michael S Kostapanos, et al.Expert Opinion on Drug Safety|May 9, 2012
Nicotinic acid: clinical considerationsAnastazia Kei, Moses S ElisafAngiology|May 14, 2010
Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece surveyMoses S Elisaf, Nikos NikasCurrent Vascular Pharmacology|May 1, 2013
Recommendations for severe hypertriglyceridemia treatment, are there new strategies?Theodosios D Filippatos, Moses S ElisafCurrent Cardiology Reports|April 23, 2017
Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?Evangelos C Rizos, Moses S ElisafExpert Opinion on Drug Safety|July 3, 2015
Safety considerations with fenofibrate/simvastatin combinationTheodosios D Filippatos, Moses S ElisafExpert Opinion on Pharmacotherapy|September 8, 2005
Therapeutic management of hyperglycaemic hyperosmolar syndromeHaralampos J Milionis, Moses S ElisafWorld Journal of Hepatology|November 8, 2011
Role of ezetimibe in non-alcoholic fatty liver diseaseTheodosios D Filippatos, Moses S ElisafWorld Journal of Cardiology|July 29, 2014
Antihypertensive drugs and glucose metabolismChristos V Rizos, Moses S ElisafPageof 24